UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape Journal article
Kinoshita,Shotaro, Cortright,Kelley, Crawford,Allison, Mizuno,Yuya, Yoshida,Kazunari, Hilty,Donald, Guinart,Daniel, Torous,John, Correll,Christoph U., Castle,David J., Rocha,Deyvis, Yang,Yuan, Xiang,Yu Tao, Kølbæk,Pernille, Dines,David, Elshami,Mohammad, Jain,Prakhar, Kallivayalil,Roy, Solmi,Marco, Favaro,Angela, Veronese,Nicola, Seedat,Soraya, Shin,Sangho, De Pablo,Gonzalo Salazar, Chang,Chun Hung, Su,Kuan Pin, Karas,Hakan, Kane,John M., Yellowlees,Peter, Kishimoto,Taishiro. Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape[J]. Psychological Medicine, 2020, 52(13), 2606-2613.
Authors:  Kinoshita,Shotaro;  Cortright,Kelley;  Crawford,Allison;  Mizuno,Yuya;  Yoshida,Kazunari; et al.
Favorite | TC[WOS]:48 TC[Scopus]:53  IF:5.9/6.5 | Submit date:2021/03/02
Covid-19  Government Regulation  Health Insurance Reimbursement  Telemedicine  Telepsychiatry  
Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009) Journal article
Xiang, Yu-Tao, Kato, Takahiro A., Kishimoto, Taishiro, Ungvari, Gabor S., Chiu, Helen F. K., Si, Tian-Mei, Yang, Shu-Yu, Fujii, Senta, Ng, Chee H., Shinfuku, Naotaka. Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009)[J]. ASIA-PACIFIC PSYCHIATRY, 2017, 9(4).
Authors:  Xiang, Yu-Tao;  Kato, Takahiro A.;  Kishimoto, Taishiro;  Ungvari, Gabor S.;  Chiu, Helen F. K.; et al.
Favorite | TC[WOS]:8 TC[Scopus]:7  IF:2.8/3.0 | Submit date:2018/10/30
China  Ethnicity  Japan  Prescription  Schizophrenia  
Worldwide Differences in Regulations of Clozapine Use Journal article
Jimmi Nielsen, Corina Young, Petru Iften, Taishiro Kishimoto, Yu-Tao Xiang, Peter F. J. Schulte, Christoph U. Correll, David Taylor. Worldwide Differences in Regulations of Clozapine Use[J]. CNS Drugs, 2016, 30(2), 149–161.
Authors:  Jimmi Nielsen;  Corina Young;  Petru Iften;  Taishiro Kishimoto;  Yu-Tao Xiang; et al.
Favorite | TC[WOS]:133 TC[Scopus]:143 | Submit date:2019/01/07
Clozapine  Myocarditis  Absolute Neutrophil Count  Schizoaffective Disorder  Agranulocytosis